Baptist Health Oncology Research

Lexington, Kentucky 40503

0 studies enrolling now · 1 studies all time

What they study most

Non-small Cell Lung Cancer

Studies at this site

• EF-36/Keynote B36: A Pilot, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Pembrolizumab for First Line Treatment of Advanced or Metastatic Non-small Cell Lung Cancer — Stopped early